Skip to main content
Premium Trial:

Request an Annual Quote

MNG Laboratories Carrier Exome

MNG Laboratories has introduced the MNG Carrier Exome, a test to determine carrier status for recessive disorders like cystic fibrosis, sickle cell anemia, and Tay-Sachs disease. The test is designed to detect a wide range of rare family or sub-population specific variants that could have an adverse effect in offspring. Whole exome sequencing is performed on both partners in order to detect shared known pathogenic and predicted disruptive variants in genes that are causative of autosomal recessive disorders. This test is intended for prospective parents who are interested in the most complete review of their genetic background to better understand their risk of having children with rare autosomal recessive disorders. It is not recommended for diagnostic purposes.

In addition to the MNG Carrier Exome, MNG Laboratories is launching a Pan-European Carrier Screen test and an Ashkenazi Jewish Carrier Screen test.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.